A new publication involving LL-37 appeared on August 6, 2026. The study, titled "Antibiotic loaded solid lipid nanoparticles target bacteria in a pyogenic spondylitis rat model," was published in the journal Discover Nano.
LL-37 remains classified as an unapproved research compound. This entry reflects the appearance of the publication itself, not any claims about outcomes or efficacy described within it.
The publication record is indexed under PubMed ID 42560613 and is available through the linked PubMed entry. No specific results, safety findings, or conclusions from the study are summarized here, as this brief reports only on the existence and details of the publication event.
Readers interested in the broader context of LL-37 as a research compound, including its regulatory status and general background, can consult the compound overview for further information.